Back to Legal & General Group Plc Legal & General Group Plc

ZVRAZVRA
Showing 8 of 18 quarters

Position history for Legal & General Group PlcLegal & General Group Plc's holdings in ZEVRA THERAPEUTICS INC

Yes. Legal & General Group holds 1,201,668 shares of ZVRA (Zevra Therapeutics), worth $17.2M, as of its Q2 2026 13F filing. It increased the position by 38,578 shares (+3.3%) from Q1 2026. Legal & General Group has held ZVRA since Q2 2023, across 13 quarterly 13F filings.

Current Value

$17.2M

Current Shares

1.2M

Total Value Change

+$17.2M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+3.3%
$17.2M0.0%$14.34
29
2026-Q1
Increased
1.2M
+5.9%
$10.8M0.0%$8.91
29
2025-Q4
Increased
1.1M
+4.2%
$9.8M0.0%$8.81
29
2025-Q3
Increased
1.1M
+12.6%
$10M0.0%$9.54
31
2025-Q2
Increased
935,677
+26.8%
$8.2M0.0%$9.00
34
2025-Q1
Increased
737,737
+138x
$5.5M0.0%$7.85
44
2024-Q4
Increased
5,301
+16.8%
$44,2100.0%$8.21
16
2024-Q3
Increased
4,539
+17.9%
$31,5000.0%$6.92
16

Other major holders of ZVRA: BlackRock, Inc., FMR LLC, Woodline Partners LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used